Coronavirus: Vaccination

(asked on 5th March 2021) - View Source

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if his Department will provide additional funding for research projects investigating the efficacy of the coronavirus vaccines for blood cancer patients.


Answered by
Edward Argar Portrait
Edward Argar
Minister of State (Ministry of Justice)
This question was answered on 15th March 2021

There is a breadth of research activity being undertaken, including by UK Research and Innovation (UKRI), to better understand the effects of COVID-19 vaccination on individuals that are immunocompromised, including those with blood cancers. Specifically, as part of the National Core Studies Immunity Programme, UKRI has provided initial funding of £1.8 million towards the OCTAVE study looking at vaccine responses in groups of immune suppressed individuals, including in cancer and blood cancer patients.

UKRI is also supporting the Data and Connectivity National Core Studies programme with an investment of up to £8.2 million to date to enable the real-world evaluation of vaccine uptake and efficacy across all populations, including cancer patients.

Reticulating Splines